Cointime

NeuroSigma

company

About

NeuroSigma develops and commercializes trigeminal nerve stimulation (TNS) for a variety of neurologic and psychiatric disorders.

  • 11 - 50

Highlights

Total Funding Amount
$5M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Corporate Round
Last Funding Money Raised
$5M
Industries
Biotechnology,Developer Platform,Medical
Founded date
Jan 1, 2008
Number Of Employee
11 - 50
Operating Status
Active

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$5M
NeuroSigma has raised a total of $5M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2021 from a Corporate Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 8, 2021 Corporate Round $5M 1 KT Corp — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
NeuroSigma is funded by 1 investors. KT Corp are the most recent investors.
Investor Name Lead Investor Funding Round
KT Corp Yes Corporate Round
Cointime
Content
Company